GRAFT-VERSUS-HOST-DISEASE
Clinical trials for GRAFT-VERSUS-HOST-DISEASE explained in plain language.
Never miss a new study
Get alerted when new GRAFT-VERSUS-HOST-DISEASE trials appear
Sign up with your email to follow new studies for GRAFT-VERSUS-HOST-DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to tame deadly transplant complication
Disease control TerminatedThis study tested a combination of drugs (cyclophosphamide, sirolimus, and sometimes azacitidine) to help people whose graft-versus-host disease (GVHD) did not improve with steroids. GVHD is a serious condition where donor immune cells attack the patient's body after a stem cell …
Matched conditions: GRAFT-VERSUS-HOST-DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Immune secrets of light therapy for transplant complications revealed
Knowledge-focused TerminatedThis study looked at how extracorporeal photopheresis (ECP) — a treatment that uses light to modify a patient's own blood cells — affects the immune system in people with chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. Researchers planned t…
Matched conditions: GRAFT-VERSUS-HOST-DISEASE
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC